Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.150
-0.040 (-3.36%)
Aug 28, 2026, 3:28 PM EDT - Market open
Milestone Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 169.73 | 73.05 | 25.31 | 13.76 | 7.64 | 114.14 |
Short-Term Investments | 0.88 | 32.91 | 44.38 | 52.24 | 56.95 | - |
Cash & Short-Term Investments | 170.61 | 105.96 | 69.7 | 66 | 64.59 | 114.14 |
Cash Growth | 292.95% | 52.03% | 5.59% | 2.20% | -43.42% | -19.79% |
Other Receivables | 1.24 | 3.51 | 1.72 | 1.45 | 1.21 | 0.48 |
Receivables | 3.96 | 3.51 | 1.72 | 1.45 | 1.21 | 0.48 |
Inventory | 4.72 | 0.65 | - | - | - | - |
Prepaid Expenses | 1.04 | 1.81 | 1.84 | 3.18 | 6.01 | 4.3 |
Other Current Assets | - | - | 0.67 | 2.4 | - | - |
Total Current Assets | 180.33 | 111.92 | 73.93 | 73.03 | 71.8 | 118.92 |
Property, Plant & Equipment | 1.3 | 1.64 | 1.57 | 2.19 | 2.68 | 0.93 |
Total Assets | 181.63 | 113.56 | 75.5 | 75.23 | 74.48 | 119.85 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8.45 | 5.65 | 1.93 | 3.98 | 2.26 | 4.38 |
Accrued Expenses | 10.48 | 6.34 | 5.62 | 2.7 | 3.38 | 2.17 |
Current Portion of Leases | 0.67 | 0.65 | 0.57 | 0.55 | 0.5 | 0.22 |
Other Current Liabilities | 1.54 | 1.35 | - | - | - | - |
Total Current Liabilities | 22.18 | 13.98 | 8.13 | 7.23 | 6.14 | 6.78 |
Long-Term Debt | 140.97 | 57.19 | 53.35 | 49.77 | - | - |
Long-Term Leases | 0.19 | 0.54 | 0.87 | 1.46 | 2 | 0.47 |
Other Long-Term Liabilities | 0.06 | 0.08 | - | - | - | - |
Total Liabilities | 163.41 | 71.79 | 62.35 | 58.46 | 8.14 | 7.25 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 384.99 | 352.62 | 288.05 | 260.5 | 273.9 | 251.9 |
Additional Paid-In Capital | 62.87 | 64.1 | 39.57 | 33.83 | 24.44 | 15.71 |
Retained Earnings | -485.28 | -430.6 | -367.55 | -326.03 | -266.34 | -207.95 |
Comprehensive Income & Other | 55.65 | 55.65 | 53.08 | 48.46 | 34.35 | 52.94 |
Total Common Equity | 18.22 | 41.77 | 13.15 | 16.77 | 66.35 | 112.6 |
Shareholders' Equity | 18.22 | 41.77 | 13.15 | 16.77 | 66.35 | 112.6 |
Total Liabilities & Equity | 181.63 | 113.56 | 75.5 | 75.23 | 74.48 | 119.85 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 141.83 | 58.38 | 54.8 | 51.78 | 2.49 | 0.7 |
Net Cash (Debt) | 28.78 | 47.58 | 14.9 | 14.23 | 62.09 | 113.44 |
Net Cash Growth | - | 219.39% | 4.71% | -77.09% | -45.26% | -19.75% |
Net Cash Per Share | 0.24 | 0.57 | 0.24 | 0.33 | 1.46 | 2.71 |
Filing Date Shares Outstanding | 140.91 | 16.41 | 66.26 | 43.06 | 42.8 | 42.23 |
Total Common Shares Outstanding | 140.91 | 122.65 | 66.26 | 43.06 | 42.8 | 42.23 |
Working Capital | 158.14 | 97.94 | 65.8 | 65.81 | 65.66 | 112.15 |
Book Value Per Share | 0.13 | 0.34 | 0.20 | 0.39 | 1.55 | 2.67 |
Tangible Book Value | 18.22 | 41.77 | 13.15 | 16.77 | 66.35 | 112.6 |
Tangible Book Value Per Share | 0.13 | 0.34 | 0.20 | 0.39 | 1.55 | 2.67 |
Machinery | - | 0.83 | 0.4 | 0.38 | 0.28 | 0.43 |
Leasehold Improvements | - | 0.09 | 0.09 | 0.09 | 0.1 | 0.03 |